Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Receivables (2012 - 2026)

Updated

Grace Therapeutics (GRCE) reported Receivables of $20,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 50.0% from $40,000 a year earlier and down 50.0% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Receivables (2012 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics posted Receivables of $40,000, down 84.1% from FY2025.

  • Receivables has a five-year compound annual growth rate of -40.8% (FY2021 to FY2026).
  • By fiscal year, Receivables came in at $252,000 in FY2025 (-82.5%), $1.44 million in FY2024 (+80.0%), $802,000 in FY2023 (+46.4%) and $548,000 in FY2022 (unchanged).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Receivables since fiscal Q3 2018.
  • The high point for year-over-year Receivables in five years was fiscal Q3 2023 (growth of 226.9%); the low point was fiscal Q2 2026 (a decline of 95.2%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $40,000 (Q1 2027), $40,000 (Q4 2026) and $40,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 18.99 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 13.51 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 16.16 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 5.01 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 14.19 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 40,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20,000.00
Jun 30, 2026 40,000.00
Mar 31, 2026 40,000.00
Dec 31, 2025 40,000.00
Sep 30, 2025 40,000.00
Jun 30, 2025 40,000.00
Mar 31, 2025 252,000.00
Dec 31, 2024 602,000.00
Sep 30, 2024 830,000.00
Jun 30, 2024 418,000.00
Mar 31, 2024 1.44 Mn
Dec 31, 2023 987,000.00
Sep 30, 2023 864,000.00
Jun 30, 2023 837,000.00
Mar 31, 2023 802,000.00
Dec 31, 2022 778,000.00
Sep 30, 2022 859,000.00
Jun 30, 2022 964,000.00
Mar 31, 2022 548,000.00
Dec 31, 2021 238,000.00
API Access

Grace Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GRCE&period=max&api_key=YOUR_API_KEY